Movement Disorders

The supplied grounding identifies movement disorders as a heterogeneous group with multiple etiologic categories. These include degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. No single cause applies to all movement disorders.

The defining biological feature is dyskinesia, meaning abnormal movement as the cardinal manifestation of the disease process. The grounding also indicates that physiopathology is a major literature focus, but it does not provide a single shared mechanism across the category. Some movement disorders are discussed in relation to neurodegeneration and functional neurological mechanisms, but no unified pathophysiology is supported here.

Risk factors are not specified for movement disorders as a category in the supplied grounding. The literature includes medication-induced, post-infectious, post-inflammatory, post-traumatic, degenerative, and hereditary forms, which indicate relevant etiologic contexts rather than generalizable risk factors. No broader risk profile is supported.

Treatment is described at the modality level and includes deep brain stimulation as an effective surgical treatment for medication-refractory hypokinetic and hyperkinetic movement disorders. The grounding also mentions lesioning with focused ultrasound, neuromodulation, and emerging approaches such as gene replacement therapy and RNA-targeted therapeutics for selected childhood-onset disorders. Symptomatic treatment based on phenomenology and mechanism-based precision medicine are both described as therapeutic approaches.